The most convincing evidence to date for the role of protease-independent invasiveness in the process of in vivo metastasis was given by the Chiarugi lab in a series of studies analyzing the role of EphA2 in the metastasis of melanoma [27] and prostate carcinoma [28] cells. The gene discussed is EPHA2; the disease is melanoma.